Eli Lilly Must Pay Royalties In Diabetes Drug Row, Judge Says
A federal judge has determined that Eli Lilly owes an Arizona company a portion of the billions of dollars in sales from its insulin brands, citing a 1992 royalty agreement that...To view the full article, register now.
Already a subscriber? Click here to view full article